Louisiana SB162 amends the workers' compensation medical treatment schedule, limiting appeal evidence to that reviewed by the medical director or.
Louisiana SB162 modifies the workers' compensation medical treatment schedule, specifying that only evidence reviewed by the medical director or associate medical director is admissible in appeals. This change ensures that appeals focus on the evidence considered by the medical director or associate medical director, maintaining the integrity of the decision-making process. Effective August 1, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.